Jeffrey Cummings, MD, ScD

Articles

Using Prior Success to Improve Alzheimer Trials, Drug Development: Jeffrey Cummings, MD, ScD

January 26, 2022

The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada, Las Vegas discussed how the momentum gained within the Alzheimer community can springboard success going forward. [WATCH TIME: 4 minutes]

Eliminating Wasteful Costs in Alzheimer Drug Development: Jeffrey Cummings, MD, ScD

January 05, 2022

The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas detailed the steps necessary to lower wasted costs from Alzheimer disease drug development and improve regulatory success. [WATCH TIME: 4 minutes]

Jeffrey Cummings, MD, ScD: Repurposed Agents Within Alzheimer Disease Pipeline

August 24, 2020

The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada-Las Vegas discussed the role repurposed agents play in Alzheimer disease development.

Jeffrey Cummings, MD, ScD: Greatest Unmet Needs in Alzheimer Disease

August 08, 2020

The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada–Las Vegas discussed the leading challenges for those with Alzheimer disease.

Jeffrey Cummings, MD, ScD: Where Aducanumab Stands in Alzheimer Clinical Pipeline

July 29, 2020

The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada­–Las Vegas gives his thoughts on the latest aducanumab update and its potential as a treatment for Alzheimer disease.

Jeffrey Cummings, MD, ScD: Trends in the Alzheimer Disease Clinical Pipeline

July 24, 2020

The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada-Las Vegas, details trends in Alzheimer disease research over the past few years.